Lifeclean Q1’2024: Sales in line - Redeye

Redeye saw sales that were just above and results that were below our expectations. Sales were up 10% y/y and up the previous quarter, while costs were higher than expected again. The sales development is a positive factor. With the share issue and increased debt, the cash at hand at the end of the quarter stands at SEK 18.m. We will likely maintain our sales estimates for the rest of the year while increasing costs. The Base case will be adjusted slightly downwards as we change the cost levels while we still see that the agreements made recently have not yet reached the potential, which holds back any major negative revisions.

Länk till analysen i sin helhet: https://www.redeye.se/research/1003738/lifeclean-q12024-sales-in-line?utm_source=finwire&utm_medium=RSS